Research Report for the year 2017

Scientific publications

• De Bin R, Boulesteix AL, Sauerbrei W: Detection of influential points as a byproduct of resampling-based variable selection procedures. Comput Stat Data An, 2017; 116: 19-31. : http://dx.doi.org/10.1016/j.csda.2017.07.001
• Lorenz E, Jenkner C, Sauerbrei W, Becher H: Modeling Variables With a Spike at Z ero: Examples and Practical Recommendations: Am J Epidemiol, 2017; 185: 650-660. : https://doi.org/10.1093/aje/kww122
• Sekula P, Mallett S, Altman DG, Sauerbrei W: Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. Plos One, 2017; 12 (online): e0178531. : http://dx.doi.org/10.1371/journal.pone.0178531

• Boulesteix A-L, Hornung R, Sauerbrei w: On Fishing for Significance and Statistician's Degree of Freedom in the Era of Big Molecular Data. In: Max Ott, Wolfgang Pietsch, Jörg Wernecke (Hrsg.): Berechenbarkeit der Welt? Philosohpie und Wissenschaft im Zeitalter von Big Data. Wiesbaden: Springer Fachmedien Wiesbaden, 2017; 155-170.

• Altman DG, Sauerbrei W, McShane LM: Importance of the distinction between quality of methodology and quality of reporting. Hpb, 2017; 19: 649-650. : https://doi.org/10.1016/j.hpb.2017.02.444

• Kempf E, Porcher R, de Beyer J, Moons K, Altman D, Reitsma H, Hopewell S, Sauerbrei W, Collins G: Overinterpretation and misreporting of prognostic factor studies in oncology. Diagnostic and Prognostic Research, 2017; 1 Suppl. 1 (online): P39 (Methods for Evaluating Medical Tests and Biomarkers Birmingham, UK. 19–20 July 2016). : http://dx.doi.org/10.1186/s41512-016-0001-y
• Mallett S, Sekula P, Altman DG, Sauerbrei W: Reporting of prognostic tumour marker studies after the introduction of the REMARK guideline needs improvement: Diagnostic and Prognostic Research, 2017; 1 Suppl. 1 (online): P36 (Methods for Evaluating Medical Tests and Biomarkers Birmingham, UK. 19–20 July 2016). : http://dx.doi.org/10.1186/s41512-016-0001-y